Investigating Factors Associated with Depressive Symptoms of Chronic Kidney Diseases in China with Type 2 Diabetes

Xu Wang, Biyu Shen, Xun Zhuang, Weiqun WengJournal of Diabetes Research 2017 · DOI

TL;DR

This study investigated the prevalence and risk factors of depressive symptoms in Chinese patients with both Type 2 Diabetes (T2DM) and Chronic Kidney Disease (CKD). The findings highlight that being female, having hypertension, and being in the later stages of CKD (Stage IV and V) are significant predictors of depressive symptoms, underscoring the need for integrated psychological care in managing these complex patients.

What Problem Does This Paper Address?

Type 2 Diabetes Mellitus (T2DM) is a growing epidemic, and a significant complication is Chronic Kidney Disease (CKD), which can progress to end-stage renal disease. Simultaneously, depression is a major global health issue, and its co-occurrence with T2DM is known to worsen patient outcomes and self-management. While the link between depression and T2DM is established, and depression is also prevalent in CKD patients, the specific factors contributing to depressive symptoms in the combined population of T2DM and CKD patients in China remained less understood. This paper aims to fill that gap by identifying these specific risk factors to inform better clinical awareness and intervention strategies.

Methods

This research employed a cross-sectional analytical study design. A cohort of 210 T2DM patients with CKD was recruited from the Second Affiliated Hospital of Nantong University. Depressive symptoms were assessed using the depression subscale (HAD-D) of the Hospital Anxiety and Depression Scale (HAD). Quality of life was evaluated using the RAND 36-Item Health Survey (SF-36). To identify independent risk factors for depressive symptoms, a stepwise forward logistic regression model was utilized. Statistical significance was determined at a P-value of less than 0.05.

Datasets

The study utilized data collected from 210 T2DM patients with CKD at the Second Affiliated Hospital of Nantong University. This data included demographic information, diabetes characteristics, clinical parameters (hypertension, HbA1c, plasma creatinine, albuminuria), and self-reported measures of depressive symptoms (HAD-D) and quality of life (SF-36). No new datasets or benchmarks were introduced.

Key Insights and Ideas

  • The Interplay of Chronic Conditions: This study powerfully illustrates how the burden of multiple chronic conditions (T2DM and CKD) can significantly increase the risk of mental health issues like depression.
  • Vulnerable Subgroups Identified: The research pinpoints specific patient characteristics (female gender, hypertension, advanced CKD stages) that place individuals at a much higher risk, allowing for targeted screening and support.
  • Quality of Life Impact: The clear correlation between higher depressive symptom scores and poorer quality of life reinforces the holistic impact of these conditions on a patient's well-being.
  • Clinical Implications: The findings directly inform clinical practice, suggesting that healthcare providers should be particularly vigilant about the psychological health of female T2DM-CKD patients, especially those with hypertension and advanced kidney disease.

Key Results

  • Approximately 21.4% of the study participants reported depressive symptoms (defined as a HAD-D score ≥ 11).
  • Forward stepwise logistic regression identified the following as significant independent risk factors for depressive symptoms:
  • Female gender: (P = 0.010)
    • Hypertension: (P = 0.022)
    • Stage IV CKD: (P = 0.003)
    • Stage V CKD: (P < 0.001)
  • Patients with hypertension were 2.5 times more likely to experience depressive symptoms than those without.
  • Patients in Stage IV CKD were 6.5 times more likely, and those in Stage V were 11.8 times more likely, to report depressive symptoms compared to Stage I.
  • Female patients were 2.6 times more likely to report depressive symptoms than male patients.
  • Individuals with HAD-D scores below 11 (indicating fewer depressive symptoms) reported significantly better quality of life across all SF-36 domains compared to those with HAD-D scores of 11 or higher.

Limitations and Future Work

The authors acknowledge several limitations:

  • Convenience Sample: The study was conducted at a single hospital, limiting its generalizability to the broader T2DM-CKD population in China.
  • Self-Reported Data: Reliance on questionnaires introduces potential for recall bias and social desirability bias.
  • Exclusion of Complications/Treatments: The study did not account for the impact of other complications or specific treatments (like dialysis or transplantation), which could influence depressive symptoms.
  • Sample Size: The relatively smaller sample size may have prevented the detection of associations with other factors previously identified in other studies (e.g., age, employment status, income, education, HbA1c).

Future research could benefit from larger, multi-center studies, incorporate objective measures where possible, and explore the impact of specific CKD treatments and comorbidities. The authors suggest that targeted depression interventions should be considered for this vulnerable population, particularly those in later stages of CKD.

Summary updated

Abstract

<i>Aim.</i> To assess the depressive symptoms status of chronic kidney diseases in Nantong, China, with type 2 diabetes and to identify factors associated with depressive symptoms. <i>Methods.</i> In this cross-sectional analytic study, 210 type 2 diabetic patients were recruited from the Second Affiliated Hospital of Nantong University. Depressive symptoms were assessed with the depression subscale of the Hospital Anxiety and Depression Scale (HAD-D). The quality of life was measured with the RAND 36-Item Health Survey (SF-36). And the independent risk factors of depressive symptoms were assessed by using a stepwise forward model of logistic regression analysis. <i>Results.</i> The mean age of the study subjects was 57.66 years (SD: 11.68). Approximately 21.4% of subjects reported depressive symptoms (<i>n</i> = 45). Forward stepwise logistic regression analysis showed that female gender (<i>P</i> = 0.010), hypertension (<i>P</i> = 0.022), Stage IV (<i>P</i> = 0.003), and Stage V (<i>P</i> < 0.001) were significant risk factors for depressive symptoms. The quality of life of individuals with HAD-D score <11 was significantly better compared with individuals with HAD-D score ≥ 11. <i>Conclusions.</i> These results indicate that clinicians should be aware that female patients with chronic kidney diseases with T2DM in their late stage with hypertension are at a marked increased risk of depressive symptoms. Providing optimal care for the psychological health of this population is vital.
BibTeX
@article{wang2017investigating,
  author = {Xu Wang and Biyu Shen and Xun Zhuang and Xueqin Wang and Weiqun Weng},
  title = {{Investigating Factors Associated with Depressive Symptoms of Chronic Kidney Diseases in China with Type 2 Diabetes}},
  journal = {Journal of Diabetes Research},
  year = {2017},
  doi = {10.1155/2017/1769897},
}
Figure